We are right in the middle of the flu season, when more and more tests come back positive for the influenza virus. Next to the common cold, there's probably no more familiar illness than the seasonal flu: If you don't get it, someone you know does. Despite this familiarity, there are some fascinating facts about the flu that most of us do not know. Learning about influenza reveals a global network of researchers whose daily work keeps this virus at bay.
The Centers for Disease Control's Global Safe Healthcare division refers to infection prevention and control as "the cornerstone of a resilient healthcare system and protects health workers, patients, and the surrounding community." This quote got us thinking about the role of a cornerstone, and how it does indeed reflect the critical position IC plays in community health. In today's post, we'll see just how far this metaphor goes in capturing the many ways infection control and prevention impacts quality healthcare.
Eradicating pathogens from environmental surfaces in hospitals is a daily fight. Keeping bacteria from reproducing on surfaces, finding reservoirs in hard-to-clean areas, and forming biofilms requires daily disinfection, and ideally, some form of continuous mitigation. In today's post, we will look at the threats posed by bacteria that are even more adept at surviving on surfaces: Spore-forming bacteria, and how hospitals are trying to keep these persistent pathogens from threatening their patients.
If you spend any time at all in the world of infection control and prevention, you've run across the NHSN, or National Healthcare Safety Network. Those of us who are not directly involved with infection control, however, may lack a full understanding of what the NHSN truly is. Today's post is for those of us who work on the periphery of infection control efforts: An introduction to the NHSN.
A couple years back, the EOSCU Team had the honor of presenting at the Centers for Disease Control and Prevention (CDC) campus outside of Atlanta, GA. During the meeting with the Division of Healthcare Quality Promotion, we were able to share information about our product as well as data from our first clinical study. This meeting was anything but one-sided, however - the experts at the CDC were able to identify directions and partnerships we should explore in the future. This visit prompted us to present this post about the CDC, and what it does for our nation and the world on a daily basis.
The Centers for Disease Control and Prevention (CDC) recently released a report addressing the impact COVID-19 has had on antimicrobial resistance. While other reports have covered the incidence of hospital-associated infections during COVID, this report focused on the prevalence of drug-resistant strains of the pathogens causing the HAIs. The report reveals that the top drug-resistant pathogens are transmitted via contaminated surfaces, which become reservoirs for these strains that elude our most powerful treatments. In today's post, we will share their findings and their implications for infection prevention.
